GSK Factory in Tianjin Affected by Explosion
GSK reports no employee injuries at the facility and is assessing damage.
A GlaxoSmithKline factory located in Tianjin, China-near the site of an Aug. 12, 2015 warehouse explosion-was affected but no employees were injured, according to a company statement. The company has two facilities in the area.
The statement reports that the company has taken “urgent measures to ensure the safety of employees and their families, and to assess plant damage.”
GlaxoSmithKline (Tianjin) Co., Ltd. and American Tianjin Smith Kline Pharmaceutical Co., Ltd. will jointly donate one million yuan ($156,00) to the China Red Cross and is ready to provide any drugs for the recovery effort, the statement reports.
The explosion in an industrial area of the port city has claimed more than 100 lives, with more than 100 people listed as missing.
Source: GSK China (requires translation)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
